Researchers at the University of Queensland have identified a crucial mechanism in mitochondrial DNA (mtDNA) that helps regulate the inheritance of disease-causing mutations. This mechanism involves a chemical modification called …
A recent study conducted by Great Place to Work has positioned the BioPharma sector among the top-ranking industries for employee wellbeing in the UK. The study, part of the "State …
New research from the University of Rochester demonstrates the potential of a drug commonly used to induce labor in restoring the brain's waste disposal system, offering new hope for treating …
In a groundbreaking study published in Cell Metabolism in July 2024, researchers introduced "ThermoFace," a mew method that utilizes thermal facial imaging to assess biological age and predict the presence …
The NHS is under unprecedented strain, with wait and referral times reaching record highs and a £749 million overspend leading to a budget deficit across trusts in the UK. Despite …
A global initiative is underway to create consensus definitions for diverse intelligent systems, including AI, LLMs, and biological intelligences. Led by Cortical Labs, the biological computing startup known for "Dishbrain," …
A clinical trial of a novel off-the-shelf stem cell therapy for knee osteoarthritis has shown significant improvements in pain relief and joint function, offering hope for patients suffering from this …
If we talk about tech advances in pharma and biotech, the year 2024 has been a blast so far! Last December I compiled a list of 11 Biopharma Trends to …
As the biotech sector recovers to pre-COVID investment levels, venture capital firms have become more selective in their funding choices. In 2024, private U.S. drug companies raised $3.8 billion in …
Brain-Computer Interfaces (BCIs) have captured the public imagination, largely due to high-profile projects like Neuralink from Elon Musk's, who revealed planned improvements to their modus operandi. However, the BCI landscape …
Element Biosciences has raised over $277 million in a Series D funding round to further develop and commercialize its DNA sequencing and multi-omics technologies. The oversubscribed round was led by …
In 1986, Danish scientist Jens Juul Holst discovered that the gut hormone GLP-1 stimulates insulin and suppresses appetite. This research led to the development of two blockbuster weight-loss drugs: Wegovy …
We use cookies to personalise content and to analyse our traffic.
You consent to our cookies if you continue to use our website. Read more details in our
cookies policy.